Skip to main navigation
Skip to main content
  • Email Alerts
  • News
  • Lilly.com
  • Stock Info
    Expand mega menu
    Expand submenu
    Stock Info
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Dividends & Stock Splits
  • Webcasts & Presentations
  • Financials
    Expand mega menu
    Expand submenu
    Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Key Ratios
    • Interactive Financials
    • Debt Securities
  • Individual Investors
  • Resources
    Expand mega menu
    Expand submenu
    Resources
    • Clinical Development Pipeline
    • Current Medicines
    • Executive Committee
    • Key Facts
    • 2019 Integrated Summary Report
    • Corporate Responsibility Reports
  • Email Alerts
  • News
  • Lilly.com

Investors

Investors

Latest News

September 22, 2020

Trulicity® (dulaglutide) is now indicated as an adjunct to diet, exercise, and standard of care therapy to reduce the risk of non-fatal stroke in adults with type 2 diabetes mellitus who have multiple cardiovascular risk factors or established cardiovascu

September 20, 2020

Verzenio® Significantly Reduced the Risk of Cancer Recurrence by 25% for People with HR+, HER2- High Risk Early Breast Cancer

September 18, 2020

CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Atopic Dermatitis

View All

Latest Events

October 27, 2020 at 9:00 AM EDT

Q3 2020 Earnings Call

December 15, 2020 at 9:00 AM EST

2021 Guidance Call

January 29, 2021 at 9:00 AM EST

Q4 2020 Earnings Call

April 27, 2021 at 9:00 AM EDT

Q1 2021 Earnings Call

August 3, 2021 at 9:00 AM EDT

Q2 2021 Earnings Call

View All
two people talking in library with laptop

Clinical Development Pipeline

Learn More
"when we fulfill our purpose, we help others fulfill theirs" in white letters on a red background

Quarterly Results

View Results
"when we fulfill our purpose, we help others fulfill theirs" in white letters on a red background

2019 Integrated Summary Report

View This Report
people talking at the table of a team building lunch with red balloons

Key Ratios

Key Financial Ratios
wide shot of two scientists in lab

Investor Email Alerts

Sign up to receive email alerts for various types of investor content.

Diversity
Contact
Suppliers
Login
Terms of Use
Privacy Statement
Accessibility Statement
Sitemap

To speak to customer support:
Call (800) 545-5979

Copyright © 2020 Eli Lilly and Company. All rights reserved.
Twitter Facebook Instagram LinkedIn YouTube
Terms of Use Privacy Statement Accessibility Statement Sitemap